• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本男性下尿路症状的 15 年纵向社区研究自然史。

Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.

机构信息

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.

出版信息

BJU Int. 2012 Oct;110(7):1023-9. doi: 10.1111/j.1464-410X.2011.10866.x. Epub 2012 Jan 11.

DOI:10.1111/j.1464-410X.2011.10866.x
PMID:22233355
Abstract

UNLABELLED

Study Type - Symptom prevalence (cohort) Level of Evidence 2b. What's known on the subject? and What does the study add? There have been few longitudinal community-based studies on LUTS suggestive of BPH. It is important to determine the natural history of LUTS suggestive of BPH among men in various countries because it is known that there are differences according to race. Although we previously reported a cross-sectional community-based survey on LUTS suggestive of BPH in Japanese men, no longitudinal data were available. The present study provides 15-year longitudinal data on LUTS suggestive of BPH and related variables in Japanese men.

OBJECTIVE

To report the natural history of benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) in Japanese men.

PATIENTS AND METHODS

From 1992 to 1993, we conducted a cross-sectional community-based study on LUTS suggestive of BPH in Japanese men aged 40-79 years. • After 15 fifteen years, a follow-up study was conducted to determine their longitudinal changes of LUTS. • Of the 319 participants taking part in the initial study, 135 participated again in the follow-up study. • We investigated International Prostate Symptom Score (IPSS), quality of life index and bother score using a questionnaire, and measured prostate volume (PV), prostate-specific antigen (PSA) level and peak urinary flow rate (Q(max) ) using a method that we have employed previously.

RESULTS

The change in the total IPSS during 15 years was significant (P= 0.001) and its mean (sd) annual change was 0.11 (0.40). • Although there was little change in the bother score, a significant correlation was observed between changes in the IPSS and bother score (r= 0.528, P < 0.001). • For the individual IPSS and bother scores, only changes in urgency, weak stream and nocturia were significant. • The changes in PV, PSA level and Q(max) were significant. • The change in the total IPSS did not correlate with the changes in these variables.

CONCLUSION

In a 15-year-longitudinal community-based study for Japanese men, we have shown that the IPSS and quality of life index deteriorated, PV and PSA level increased, and Q(max) decreased.

摘要

未加标签

研究类型 - 症状流行率(队列)证据水平 2b。 关于这个主题已经知道了什么? 这项研究有什么新发现? 关于提示前列腺增生症(BPH)的下尿路症状(LUTS)的纵向社区研究很少。 确定不同国家男性提示 BPH 的 LUTS 的自然病史很重要,因为已知根据种族存在差异。 虽然我们之前报告了一项关于日本男性提示 BPH 的 LUTS 的横断面社区研究,但没有可用的纵向数据。 本研究提供了日本男性提示 BPH 的 LUTS 及相关变量的 15 年纵向数据。

目的

报告日本男性良性前列腺增生症(BPH)/下尿路症状(LUTS)的自然病史。

患者和方法

1992 年至 1993 年,我们对 40-79 岁的日本男性进行了一项关于提示 BPH 的 LUTS 的横断面社区研究。 • 15 年后,进行了一项随访研究,以确定他们的 LUTS 纵向变化。 • 在最初研究中参加的 319 名参与者中,有 135 名再次参加了随访研究。 • 我们使用问卷调查了国际前列腺症状评分(IPSS)、生活质量指数和困扰评分,并使用我们之前使用的方法测量了前列腺体积(PV)、前列腺特异性抗原(PSA)水平和最大尿流率(Q(max))。

结果

15 年内总 IPSS 的变化具有统计学意义(P=0.001),其平均(标准差)年变化为 0.11(0.40)。 • 尽管困扰评分变化不大,但 IPSS 和困扰评分之间存在显著相关性(r=0.528,P<0.001)。 • 对于个体的 IPSS 和困扰评分,只有尿急、弱流和夜尿症的变化具有统计学意义。 • PV、PSA 水平和 Q(max) 的变化具有统计学意义。 • 总 IPSS 的变化与这些变量的变化无关。

结论

在一项针对日本男性的 15 年纵向社区研究中,我们表明 IPSS 和生活质量指数恶化,PV 和 PSA 水平升高,Q(max) 降低。

相似文献

1
Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.日本男性下尿路症状的 15 年纵向社区研究自然史。
BJU Int. 2012 Oct;110(7):1023-9. doi: 10.1111/j.1464-410X.2011.10866.x. Epub 2012 Jan 11.
2
Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.国际前列腺症状评分和核心下尿路症状评分评估男性下尿路症状。
BJU Int. 2012 May;109(10):1512-6. doi: 10.1111/j.1464-410X.2011.10445.x. Epub 2011 Aug 26.
3
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.良性前列腺增生(BPH)与前列腺炎:临床诊断为BPH的男性中射精疼痛的患病率
BJU Int. 2005 Mar;95(4):571-4. doi: 10.1111/j.1464-410X.2005.05341.x.
4
A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.良性前列腺增生经尿道前列腺切除术、接触式激光前列腺切除术和电汽化术 10 年随访;一项随机对照试验的长期结果。
BJU Int. 2010 Sep;106(6):822-6. doi: 10.1111/j.1464-410X.2010.09229.x. Epub 2010 Feb 22.
5
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.男性下尿路症状提示良性前列腺增生伴射精功能障碍。
BJU Int. 2009 Oct;104(7):974-83. doi: 10.1111/j.1464-410X.2009.08503.x. Epub 2009 May 7.
6
Natural history of lower urinary tract symptoms: preliminary report from a community-based Indian study.下尿路症状的自然史:一项基于社区的印度研究的初步报告。
BJU Int. 2004 Aug;94(3):332-4. doi: 10.1111/j.1464-410X.2004.04931.x.
7
Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.对良性前列腺增生患者的国际前列腺症状评分、前列腺特异性抗原和前列腺体积进行纵向随访观察。
Int J Urol. 2007 Apr;14(4):321-4; discussion 325. doi: 10.1111/j.1442-2042.2007.01596.x.
8
Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.每日一次他达拉非治疗下尿路症状提示良性前列腺增生症男性患者的疗效和安全性:一项国际随机、双盲、安慰剂对照试验的结果。
Eur Urol. 2011 Nov;60(5):1105-13. doi: 10.1016/j.eururo.2011.08.005. Epub 2011 Aug 12.
9
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.每日一次服用10毫克阿夫唑嗪治疗良性前列腺增生:3年现实生活实践经验
BJU Int. 2008 Apr;101(7):847-52. doi: 10.1111/j.1464-410X.2008.07458.x.
10
The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.基线参数对有症状的良性前列腺增生和前列腺肿大男性使用度他雄胺、坦索罗辛及联合治疗后国际前列腺症状评分变化的影响:CombAT研究的2年数据
Eur Urol. 2009 Feb;55(2):461-71. doi: 10.1016/j.eururo.2008.10.037. Epub 2008 Nov 6.

引用本文的文献

1
Natural history of lower urinary tract symptoms and voiding parameters in ageing men with 5-year follow-up-the concord health and ageing in men project (CHAMP).老年男性下尿路症状和排尿参数的自然史:5年随访——男性健康与衰老一致性项目(CHAMP)
Age Ageing. 2025 Mar 28;54(4). doi: 10.1093/ageing/afaf078.
2
Water Vapor Energy Therapy Safely Reduces Urinary Medication Use: A Multicenter Retrospective Real-World Study in Japan (SCCOP Study 24-01).水蒸气能量疗法可安全减少泌尿药物使用:日本一项多中心回顾性真实世界研究(SCCOP研究24 - 01)
Int J Urol. 2025 Jul;32(7):804-810. doi: 10.1111/iju.70052. Epub 2025 Mar 29.
3
Which characteristics are associated with changes in medication status for lower urinary tract symptoms among patients with prostate cancer receiving external beam radiotherapy?
在接受体外放射治疗的前列腺癌患者中,哪些特征与下尿路症状的药物治疗状态变化相关?
Curr Urol. 2024 Jun;18(2):122-127. doi: 10.1097/CU9.0000000000000194. Epub 2024 Jun 21.
4
Lower Urinary Tract Symptoms in Depression: A Review.抑郁症中的下尿路症状:综述
Health Psychol Res. 2023 Jul 15;11:81040. doi: 10.52965/001c.81040. eCollection 2023.
5
Lower urinary tract symptom severity, urinary bother, and incident life-space mobility restriction among older men.老年男性下尿路症状严重程度、排尿困扰和生活空间移动受限的发生率。
J Am Geriatr Soc. 2023 Apr;71(4):1093-1104. doi: 10.1111/jgs.18171. Epub 2022 Dec 15.
6
Association between prostatic 18F-FDG uptake and lower urinary tract symptoms assessed by International Prostate Symptom Score.通过国际前列腺症状评分评估前列腺18F-FDG摄取与下尿路症状之间的关联。
Diagn Interv Radiol. 2022 Mar;28(2):179-184. doi: 10.5152/dir.2022.20677.
7
Development and validation of prediction model for incident overactive bladder: The Nagahama study.发展和验证预测模型的事件性膀胱过度活动症:长滨研究。
Int J Urol. 2022 Jul;29(7):748-756. doi: 10.1111/iju.14887. Epub 2022 Apr 7.
8
Efficacy of holmium laser enucleation in patients with a small (less than 30 mL) prostate volume.钬激光前列腺剜除术治疗小体积前列腺(<30ml)患者的疗效。
Investig Clin Urol. 2021 May;62(3):298-304. doi: 10.4111/icu.20200450.
9
Which Happens Earlier, Lower Urinary Tract Symptoms or Erectile Dysfunction?下尿路症状和勃起功能障碍哪个出现得更早?
Sex Med. 2021 Apr;9(2):100275. doi: 10.1016/j.esxm.2020.10.003. Epub 2021 Feb 1.
10
Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH.疾病进展对中重度 BPH 相关下尿路症状患者个体 IPSS 轨迹的影响,以及即刻治疗与延迟治疗开始的后果。
World J Urol. 2020 Feb;38(2):463-472. doi: 10.1007/s00345-019-02783-x. Epub 2019 May 11.